BC Innovations | Dec 15, 2016
Translation in Brief

Fore score

Cerecor Inc. (NASDAQ:CERC) has picked up a forebrain-selective anti-epileptic compound from Eli Lilly and Co. (NYSE:LLY) that could treat seizures by blocking AMPA glutamate receptor (GRIA; GLUR) without the dose-limiting motor side effects associated with...
BC Week In Review | Oct 10, 2016
Company News

Eli Lilly, Cerecor deal

Eli Lilly granted Cerecor exclusive, worldwide rights to develop and commercialize CERC-611 (formerly LY3130418). Cerecor expects to begin Phase I testing of the transmembrane AMPAR regulatory protein gamma-8 ( TARP gamma-8 ; CACNG8 )-dependent AMPA glutamate...
Items per page:
1 - 2 of 2